Angiotensin II induced catabolic effect and muscle atrophy are redox dependent

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 217-221

  Semprun Prieto, Laura C ^a   Sukhanov, Sergiy ^a   Yoshida, Tadashi ^a   Rezk, Bashir M ^a   Gonzalez Villalobos, Romer A ^a   Vaughn, Charlotte ^a   Michael Tabony, A ^a   Delafontaine, Patrice ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Atrophy; NADPH oxidase; Oxidative stress; Skeletal muscle

Indexed keywords

ANGIOTENSIN II; APOCYNIN; PROTEASOME; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CATABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; WEIGHT REDUCTION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NADPH OXIDASE; OXIDATION-REDUCTION; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES; SUPEROXIDES; WASTING SYNDROME;

ANIMALIA; MUS;

EID: 79957921304     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.122     Document Type: Article

References (33)

1. Anker S.D., Steinborn W., Strassburg S. Cardiac cachexia. Ann. Med. 2004, 36:518-529.
2. Adigun A.Q., Ajayi A.A. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. Eur. J. Heart Fail. 2001, 3:359-363.
3. Chamberlain J.S. ACE inhibitor bulks up muscle. Nat. Med. 2007, 13:125-126.
4. Brink M., Wellen J., Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest. 1996, 97:2509-2516.
5. Brink M., Price S.R., Chrast J., Bailey J.L., Anwar A., Mitch W.E., Delafontaine P. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 2001, 142:1489-1496.
6. Blendea M.C., Jacobs D., Stump C.S., McFarlane S.I., Ogrin C., Bahtyiar G., Stas S., Kumar P., Sha Q., Ferrario C.M., Sowers J.R. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. Am. J. Physiol. Endocrinol. Metabol. 2005, 288:E353-359.
7. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996, 97:1916-1923.
8. Wei Y., Sowers J.R., Nistala R., Gong H., Uptergrove G.M., Clark S.E., Morris E.M., Szary N., Manrique C., Stump C.S. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J. Biol. Chem. 2006, 281:35137-35146.
9. Gomes-Marcondes M.C., Tisdale M.J. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett. 2002, 180:69-74.
10. Lawler J.M., Song W., Demaree S.R. Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Radic. Biol. Med. 2003, 35:9-16.
11. Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.T., Epstein C.J., Roberts L.J., Csete M., Faulkner J.A., Van Remmen H. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 2006, 40:1993-2004.
12. Buck M., Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 1996, 15:1753-1765.
13. Dorenkamp M., Riad A., Stiehl S., Spillmann F., Westermann D., Du J., Pauschinger M., Noutsias M., Adams V., Schultheiss H.P., Tschope C. Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism. Eur. J. Pharmacol. 2005, 520:179-187.
14. Sukhanov S., Higashi Y., Shai S.Y., Vaughn C., Mohler J., Li Y., Song Y.H., Titterington J., Delafontaine P. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2684-2690.
15. Gross E.R., LaDisa J.F., Weihrauch D., Olson L.E., Kress T.T., Hettrick D.A., Pagel P.S., Warltier D.C., Kersten J.R. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1552-1559.
16. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchkov M., Thaiss F., Stahl R.A., Warnholtz A., Meinertz T., Griendling K., Harrison D.G., Forstermann U., Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 2001, 88:E14-22.
17. Attaix D., Ventadour S., Codran A., Bechet D., Taillandier D., Combaret L. The ubiquitin-proteasome system and skeletal muscle wasting. Essays Biochem. 2005, 41:173-186.
18. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994, 74:1141-1148.
19. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997, 95:588-593.
20. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 2000, 86:494-501.
21. Manrique C., Lastra G., Gardner M., Sowers J.R. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med. Clin. North Am. 2009, 93:569-582.
22. Russell S.T., Eley H., Tisdale M.J. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II. Cell. Signal. 2007, 19:1797-1806.
23. Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001, 269:131-140.
24. Javesghani D., Magder S.A., Barreiro E., Quinn M.T., Hussain S.N. Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles. Am. J. Respir. Crit. Care Med. 2002, 165:412-418.
25. Paxton W.G., Runge M., Horaist C., Cohen C., Alexander R.W., Bernstein K.E. Immunohistochemical localization of rat angiotensin II AT1 receptor. Am. J. Physiol. 1993, 264:F989-995.
26. Zhang L., Du J., Hu Z., Han G., Delafontaine P., Garcia G., Mitch W.E. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J. Am. Soc. Nephrol. 2009, 20:604-612.
27. Song Y.H., Li Y., Du J., Mitch W.E., Rosenthal N., Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 2005, 115:451-458.
28. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., Holland S.M., Harrison D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40:511-515.
29. Pueyo M.E., Gonzalez W., Nicoletti A., Savoie F., Arnal J.F., Michel J.B. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2000, 20:645-651.
30. Kimura S., Zhang G.X., Nishiyama A., Shokoji T., Yao L., Fan Y.Y., Rahman M., Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 2005, 45:438-444.
31. Li W.G., Miller F.J., Zhang H.J., Spitz D.R., Oberley L.W., Weintraub N.L. H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J. Biol. Chem. 2001, 276:29251-29256.
32. Zhang D.X., Chen Y.F., Campbell W.B., Zou A.P., Gross G.J., Li P.L. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ. Res. 2001, 89:1177-1183.
33. Brandes R.P. Triggering mitochondrial radical release: a new function for NADPH oxidases. Hypertension 2005, 45:847-848.